Is Your Investment in Celsius Holdings, Inc. at Risk? Introduction As an investor, it’s essential to stay informed about potential risks to your investments. The Schall Law Firm recently reminded investors about a class action lawsuit against Celsius Holdings, Inc. (“Celsius”) for violations of securities laws. If you purchased securities from Celsius between February 29,…
Charmingly Eccentric Markets: A Recap U.S. Equity Markets Rebound After experiencing their worst week since November, U.S. equity markets rebounded with vigor. The S&P 500 advanced 0.7%, lifting its year-to-date gains to over 26%, while the Nasdaq 100 saw an extension of its 2024 gains to 28%. Investors were buoyed by relatively strong retail and…
Is Bitcoin Headed for a Crash? The Concerns Raised by Analysts Recently, some analysts have raised concerns about the possible crash of Bitcoin. The main driving force behind this predicted crash is the Chicago Mercantile Exchange (CME) gap. This gap in trading activity could potentially lead to a significant drop in the price of Bitcoin….
Closed-End Funds: High Distributions and Solid Returns Introduction For income investors, closed-end funds (CEFs) offer an attractive investment class that covers various asset classes and promises high distributions along with reasonable total returns. However, it is important to note that CEFs are generally characterized by higher volatility and deeper drawdowns than the broader market, making…
Economic Uncertainty in 2025 Introduction In 2025, economic uncertainty is likely to remain high, with macro forces, inflation, and geopolitical risks shaping the market. The Fed’s policies and rate hikes create challenges. Rising interest rates and high inflation, alongside the growing national debt, pose risks for both investors and the U.S. government. Volatile bond markets…
Class Action Lawsuit Filed Against Applied Therapeutics, Inc. New York City, NY / ACCESSWIRE / December 29, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or “the Company”) (NASDAQ:APLT) and certain of its officers. Class…
Hold on to Your Hats – Kyverna Therapeutics, Inc. Faces Class Action Lawsuit! What’s the Buzz? Well, well, well, Kyverna Therapeutics, Inc. finds itself in some hot water with a class action lawsuit filed against them. The legal eagles at Bronstein, Gewirtz & Grossman, LLC are leading the charge in the fight against alleged violations…
Exclusive Global License Agreement for SHR-4849 Rational Combination Opportunities in Precision Medicine Oncology IDEAYA Biosciences, Inc. has recently announced an exclusive global license agreement for SHR-4849, a Phase 1 DLL3-targeting Topo-I-payload antibody drug conjugate. This innovative program targets DLL3, which is highly expressed in Small Cell Lung Cancer (SCLC) and Neuroendocrine Tumors (NETs). With DLL3…
